Automated Immunology Testing Platform - CPRR
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- W9114F20Q0051R
- Agency
- Medical Command Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
Notice details come from SAM.gov. Updated .
About this opportunity
This notice seeks an automated immunoassay analyzer capable of running FDA approved assays for required tests on a cost-per-reportable-test basis. The Department of the Army Medical Command intends to solicit proposals to provide this equipment in support of the Dept. of Pathology and Area Laboratory Services at Landstuhl Regional Medical Center in Germany. The system must be a fully automated, random access platform using chemiluminescence or fluorescence to continuously operate and perform minimum testing capacity of 100 tests per hour. Proposals are due by April 16, 2020 to Donna Kabatek for a firm-fixed price contract with a base year and four option years from award through June 2025.
There is no set-aside designated for this procurement. The applicable NAICS code is 339112 for medical equipment and supplies manufacturing with a size standard of 1,000 employees. The Product Service Code is 6515. The RFQ is anticipated for release on April 29, 2020 on beta.SAM with quotes due 30 days thereafter. As an overseas location, there is no requirement for small business participation. Key details include the equipment must be new with an uninterruptible power supply for 15-20 minutes of backup power and have English displays/documentation.
Notice text
Automated Immunology Testing Platform on a cost-per-reportable test basis. The Regional Health Contracting Office-Europe, Bldg 3705 on Landstuhl Regional Medical Center, 66849 Landstuhl, Germany intends to solicit competitive proposals to provide an automated immunoassay analyzer capable of running FDA approved assays for all required tests. The system must be a fully automated, random access immunoassay system using direct or indirect chemiluminescence or fluorescence while providing continuous operation. The contract for this equipment is in support of the Dept. of Pathology and Area Laboratory Services (DPALS) and shall include all reagents and materials necessary to perform the specified assays, training, unscheduled and preventive maintenance, Method Validations per CLIA/NCCLS guidelines, and analyzer removal at the termination of the contract. Assay method must be capable of producing clinical results in accordance with the College of American Pathologist (CAP) and CLIP/CLIA/CLSI guidelines. Assay method must be able to perform FDA approved tests capable of producing clinical results in accordance with College of American Pathologist (CAP) and CLIP/CLIA/CLSI guidelines for, at a minimum, the following analytes: CMV IgG / IgM, HSV 1/2 IgG, Mumps IgG, Rubeola IgG, Varicella-zoster virus IgG and Lyme IgG / IgM. Minimum testing capacity of 100 tests per hour is required. Electrical requirement for this equipment shall be 220V/50Hz with English displays and supporting literature. Must be new and equipped with an un-interruptible power supply capable of providing all necessary electrical power to the analyzer system for 15 to 20 minutes. A Firm-Fixed Price contract with a base period and four (4) option years is anticipated. Planned contract performance is base period from date of contract award to 30 June 2021 and option periods running 1 July 2021 through 30 June 2025.
We are attempting to identify companies capable of and interested in participating in this competitive acquisition. Companies feeling they are capable of providing the required instruments, reagents and associated services above are encouraged to relay their interest to the POC listed below no later than 16 April 2020, 16:00 Central European Time.
The applicable North American Industrial Classification System (NAICS) Code and size standard is 339112 and 1,000, respectively. The Product/Service Code is 6515. Release of the Request for Quote (RFQ), W9114F-20-Q0051 on beta.SAM is anticipated on or about 29 April 2020, with quotes due 30 days after release. This is for an overseas location and therefore there is no Small Business Set-Aside. Point of Contact for this acquisition is, Contracting Specialist, Donna Kabatek, +49 (0)6371 94646550, donna.m.kabatek.civ@mail.mil.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Automated Immunology Testing Platform - CPRR | Award Notice | |
| Automated Immunology Testing Platform - CPRR | Solicitation | |
| Automated Immunology Testing Platform - CPRR | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity